TG Therapeutics
TGTX
#2677
Rank
โ‚น438.72 B
Marketcap
โ‚น2,818
Share price
-1.07%
Change (1 day)
86.58%
Change (1 year)

Revenue for TG Therapeutics (TGTX)

Revenue in 2024 (TTM): โ‚น22.09 Billion

According to TG Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น22.47 Billion. In 2023 the company made a revenue of โ‚น19.45 Billion an increase over the revenue in the year 2022 that were of โ‚น0.23 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TG Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น22.09 B13.61%
2023 โ‚น19.45 B8343.66%
2022 โ‚น0.23 B-53.73%
2021 โ‚น0.49 B4378.71%
2020 โ‚น11.11 M2.56%
2019 โ‚น10.83 M1.99%
2018 โ‚น10.62 M9.44%
2017 โ‚น9.71 M-6.22%
2016 โ‚น10.35 M2.26%
2015 โ‚น10.12 M4.86%
2014 โ‚น9.65 M2.59%
2013 โ‚น9.41 M802.65%
2012 โ‚น1.04 M
2011 N/A
2010 N/A
2009 N/A
2000 โ‚น0.25 B379.44%
1999 โ‚น52.16 M-61.66%
1998 โ‚น0.13 B1054.06%
1997 โ‚น11.78 M9.32%
1996 โ‚น10.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น305.01 B 1,257.31%๐Ÿ‡ฎ๐Ÿ‡ณ India
โ‚น127.73 B 468.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland